103 related articles for article (PubMed ID: 17350279)
1. Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells.
Abonyo BO; Lebby KD; Tonry JH; Ahmad M; Heiman AS
Cytokine; 2006 Dec; 36(5-6):237-44. PubMed ID: 17350279
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26).
Heiman AS; Abonyo BO; Darling-Reed SF; Alexander MS
J Interferon Cytokine Res; 2005 Feb; 25(2):82-91. PubMed ID: 15695929
[TBL] [Abstract][Full Text] [Related]
3. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation.
Abonyo BO; Alexander MS; Heiman AS
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L478-88. PubMed ID: 15863444
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional silencing of CCR3 downregulates IL-4 stimulated release of eotaxin-3 (CCL26) and other CCR3 ligands in alveolar type II cells.
Taka E; Errahali YJ; Abonyo BO; Bauer DM; Heiman AS
Cytokine; 2008 Dec; 44(3):342-51. PubMed ID: 19038554
[TBL] [Abstract][Full Text] [Related]
5. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids.
Banwell ME; Tolley NS; Williams TJ; Mitchell TJ
Cytokine; 2002 Mar; 17(6):317-23. PubMed ID: 12061839
[TBL] [Abstract][Full Text] [Related]
7. CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II.
Pechkovsky DV; Goldmann T; Ludwig C; Prasse A; Vollmer E; Müller-Quernheim J; Zissel G
Respir Res; 2005 Jul; 6(1):75. PubMed ID: 16033640
[TBL] [Abstract][Full Text] [Related]
8. Localization and expression of CCR3 and CCR5 by interleukin-1 beta in the RIN-5AH insulin-producing model system: a protective mechanism involving down-regulation of chemokine receptors.
Vassiliadis S; Balabanidou V; Papadopoulos GK; Athanassakis I
JOP; 2002 May; 3(3):66-75. PubMed ID: 12004163
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells.
Yuan Q; Campanella GS; Colvin RA; Hamilos DL; Jones KJ; Mathew A; Means TK; Luster AD
Eur J Immunol; 2006 Oct; 36(10):2700-14. PubMed ID: 16983721
[TBL] [Abstract][Full Text] [Related]
10. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.
Nakayama T; Watanabe Y; Oiso N; Higuchi T; Shigeta A; Mizuguchi N; Katou F; Hashimoto K; Kawada A; Yoshie O
J Immunol; 2010 Dec; 185(11):6472-9. PubMed ID: 20974991
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV
J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158
[TBL] [Abstract][Full Text] [Related]
12. CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.
Errahali YJ; Taka E; Abonyo BO; Heiman AS
J Interferon Cytokine Res; 2009 Apr; 29(4):227-39. PubMed ID: 19203252
[TBL] [Abstract][Full Text] [Related]
13. Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes.
Nishi N; Yamamoto S; Ou W; Muro E; Inada Y; Hamasaki Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):234-40. PubMed ID: 18774776
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor expression in rat adjuvant-induced arthritis.
Haas CS; Martinez RJ; Attia N; Haines GK; Campbell PL; Koch AE
Arthritis Rheum; 2005 Dec; 52(12):3718-30. PubMed ID: 16320322
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice.
Bracke KR; D'hulst AI; Maes T; Demedts IK; Moerloose KB; Kuziel WA; Joos GF; Brusselle GG
Clin Exp Allergy; 2007 Oct; 37(10):1467-79. PubMed ID: 17883726
[TBL] [Abstract][Full Text] [Related]
16. Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13.
van Wetering S; Zuyderduyn S; Ninaber DK; van Sterkenburg MA; Rabe KF; Hiemstra PS
Mol Immunol; 2007 Feb; 44(5):803-11. PubMed ID: 16740309
[TBL] [Abstract][Full Text] [Related]
17. Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts.
Kohan M; Puxeddu I; Reich R; Levi-Schaffer F; Berkman N
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):66-72. PubMed ID: 20143648
[TBL] [Abstract][Full Text] [Related]
18. Global gene analysis of Erigeron canadensis-treated TNF-alpha-, IL-4- and IL-1beta-stimulated A549 human epithelial cells.
Sohn SH; Ko E; Oh BG; Kim J; Choi E; Kim SH; Kim Y; Shin M; Hong M; Bae H
Ann Nutr Metab; 2009; 54(3):227-35. PubMed ID: 19521071
[TBL] [Abstract][Full Text] [Related]
19. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
20. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
